Auro PR Inc, Puerto Rico is undertaking a restructuring of its facility to enhance production volume

Auro PR Inc., a step-down wholly owned subsidiary of Aurobindo Pharma Limited, based at Caguas, Puerto Rico, is undertaking a restructuring of its facility to enhance production volume, after completion of commitment for product supply to third party by early July 2023. In view of the planned restructuring of the facility, Auro PR Inc will not be conducting any manufacturing activity until the repairs / restructuring is complete. During the previous year, Auro PR Inc contributed 1.76% of the consolidated turnover of the Company.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 718.00 as compared to the previous close of Rs. 721.40. The total number of shares traded during the day was 83503 in over 3348 trades.

The stock hit an intraday high of Rs. 724.95 and intraday low of 715.00. The net turnover during the day was Rs. 60117906.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 AuroPRInc Caguas PuertoRico ProductionEnhancmement